Results 81 to 90 of about 25,862 (171)

The Effect of Rifapentine and Rifampicin on Serum Voriconazole Levels Persist for 5 Days and 7 Days or More After Discontinuation in Tuberculosis Patients with Chronic Pulmonary Aspergillosis

open access: yesInfection and Drug Resistance
Hong Lu,* Yanmei Mao,* Ying Zeng, Pengyu Li, Pan Yan, Qunzhi Shi, Lin Liu Department of Pharmacy, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, People’s Republic of China*These ...
Lu H   +6 more
doaj  

Influencing risk factors of voriconazole-induced liver injury in Uygur pediatric patients undergoing allogeneic hematopoietic stem cell transplantation

open access: yesBMC Pediatrics
Purpose We aimed to investigated the influencing risk factors of voriconazole-induced liver injury in Uygur pediatric patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Methods This was a prospective cohort design study.
Ting Zhao   +6 more
doaj   +1 more source

Voriconazole-Induced acute interstitial pulmonary edema with angioedema: A case report

open access: yesBMC Pulmonary Medicine
Background Voriconazole is a first-line antifungal agent for invasive fungal infections. Reports of voriconazole-induced interstitial pulmonary edema are exceedingly rare.
Yuzhen Jin   +4 more
doaj   +1 more source

Voriconazole

open access: yesDrugs in R & D, 1999
openaire   +2 more sources

Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapy. [PDF]

open access: yesJ Antimicrob Chemother
Wehbe E   +17 more
europepmc   +1 more source

Interpretation of Pharmacometabolomics Results: Fingerprint of Drug Exposure or Confounder Effects? Insights from a Urinary Metabolomics Study with Voriconazole in Healthy Participants. [PDF]

open access: yesInt J Mol Sci
Chobanyan-Jürgens K   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy